July, 17 2025 Thursday 13:50 Hrs
  • SENSEX :   82,429.06

  • Top commodity trading and broking companies in India-205.42( -0.25%) 17-Jul-2025
top-arrow-market
Sensex 82435.63 -198.85  (-0.24) 17-Jul-2025
Previous Day Close
82634.48
Today's High/Low
High Low
  •  
  •  
82757.09 82397.97

Company News Details

Zydus Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532321
INE010B01027
210.5884278
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZYDUSLIFE
16.88
97463.82
EPS(TTM)
Face Value()
Div & Yield %
57.39
1
1.14
 

Zydus Lifesciences Ltd
Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Press Release
Jul 15,2025
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 15, 2025, titled 'Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg'.
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.